Please assess the completion status of the following clinical trial:

Trial Title: Improving Functions in MTBI Patients With Headache by rTMS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female age between 18 to 50~* History of MTBI based on the clinical diagnostic criteria~* History of headache more than 3 months~* No prior experience of TMS treatment~* Pre-treatment headache intensity M-VAS 30(0-100 scale) and average daily headache NPS 3(0-10 scale)~* At least one headache exacerbation per day~* A normal brain MRI in the past 3 months~Exclusion Criteria:~* Pregnancy~* History of pacemaker implant~* Any ferromagnetic(e.g. bullet fragment, shrapnel, device implant) in the brain or body that will prohibit the patients from having a brain MRI~* History of dementia, major psychiatric diseases, or life threatening diseases~* Presence of any other chronic neuropathic pain states~* History of seizure~* Pending litigation~* Lack of ability to understand the experimental protocol and to adequately communicate in English~* History of chronic headache prior to the incidence of MTBI

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Transcranial Magnetic Stimulation (Type: EXPERIMENTAL): Active-repetitive transcranial magnetic stimulation (rTMS) at the dorsal lateral prefrontal cortex.
- Sham Transcranial Magnetic Stimulation (Type: SHAM_COMPARATOR): Sham rTMS will consist of the same parameters as active, however, the subject will be shielded from the magnetic field of the coil.

Based on this trial design, predict the completion outcome and termination type (if applicable).